Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

111 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Transverse myelitis in systemic sclerosis.
Torabi AM, Patel RK, Wolfe GI, Hughes CS, Mendelsohn DB, Trivedi JR. Torabi AM, et al. Among authors: trivedi jr. Arch Neurol. 2004 Jan;61(1):126-8. doi: 10.1001/archneur.61.1.126. Arch Neurol. 2004. PMID: 14732630
Primary lateral sclerosis: clinical and laboratory features in 25 patients.
Singer MA, Kojan S, Barohn RJ, Herbelin L, Nations SP, Trivedi JR, Jackson CE, Burns DK, Boyer PJ, Wolfe GI. Singer MA, et al. Among authors: trivedi jr. J Clin Neuromuscul Dis. 2005 Sep;7(1):1-9. doi: 10.1097/01.cnd.0000176974.61136.45. J Clin Neuromuscul Dis. 2005. PMID: 19078775
Huntington chorea presenting with motor neuron disease.
Sadeghian H, O'Suilleabhain PE, Battiste J, Elliott JL, Trivedi JR. Sadeghian H, et al. Among authors: trivedi jr. Arch Neurol. 2011 May;68(5):650-2. doi: 10.1001/archneurol.2011.76. Arch Neurol. 2011. PMID: 21555641
Treatment of painful peripheral neuropathy.
Trivedi JR, Silvestri NJ, Wolfe GI. Trivedi JR, et al. Neurol Clin. 2013 May;31(2):377-403. doi: 10.1016/j.ncl.2013.01.003. Epub 2013 Mar 6. Neurol Clin. 2013. PMID: 23642715 Review.
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.
Howard JF Jr, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT, Muppidi S, Nowak RJ, O'Brien F, Wang JJ, Mantegazza R; REGAIN Study Group. Howard JF Jr, et al. Lancet Neurol. 2017 Dec;16(12):976-986. doi: 10.1016/S1474-4422(17)30369-1. Epub 2017 Oct 20. Lancet Neurol. 2017. PMID: 29066163 Clinical Trial.
Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trial.
Statland JM, Moore D, Wang Y, Walsh M, Mozaffar T, Elman L, Nations SP, Mitsumoto H, Fernandes JA, Saperstein D, Hayat G, Herbelin L, Karam C, Katz J, Wilkins HM, Agbas A, Swerdlow RH, Santella RM, Dimachkie MM, Barohn RJ; Rasagiline Investigators of the Muscle Study Group and Western ALS Consortium. Statland JM, et al. Muscle Nerve. 2019 Feb;59(2):201-207. doi: 10.1002/mus.26335. Epub 2018 Nov 26. Muscle Nerve. 2019. PMID: 30192007 Free PMC article. Clinical Trial.
111 results